Don’t Fall Over, but Medical Marijuana Just Scored a Big Victory on Capitol Hill

Although its track record at the state level may not be perfect, medical marijuana has scored far more victories than defeats in recent years.

Medical marijuana spreads its wings

Following its first approval 20 years ago in California for compassionate use cases, medical marijuana has now become legal in 24 states, as well as Washington, D.C. The latest state to legalize the use of medical marijuana was just as much of an eye-opener as the first. Pennsylvania legalized the use of liquid, pill, or oil formulations of marijuana for medicinal use in mid-April, though it did so entirely at the legislative level (i.e., without residents voting). Pennsylvania could be the first of many states taking matters into their own hands from a legalization perspective.

Medical marijuana has two primary supporters fueling its cause. In one corner we have patients and some physicians who see discernable treatment benefits from medical marijuana.GW Pharmaceuticals (NASDAQ:GWPH), a predominantly clinical-stage drug developer that’s focused on creating medicines derived from cannabinoids from the cannabis plant, is in the process of testing Epidiolex on patients with two types of childhood-onset epilepsy, Dravet syndrome and Lennox-Gastaut syndrome. In midstage studies, Epidiolex reduced seizure frequency by more than 50%! GW Pharmaceuticals’ Epidiolex is just one of many examples of the possible benefits of medical marijuana and its cannabinoids.

To read more:

Be the first to comment

Leave a Reply

Your email address will not be published.